International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

MIYAKIS, S., LOCKSHIN, M.D., ATSUMI, T., BRANCH, D.W., BREY, R.L., CERVERA, R., DERKSEN, R.H.W.M., DE GROOT, P.G. +7 more·2006·Journal of Thrombosis and Haemostasis

Cited by (1,054)

Items 601–700 of 1,054

  1. Therapeutic plasma exchange in pregnancy: A literature review
    Merlijn Wind, A.G.A. Gaasbeek, Liesbeth E.M. Oosten, Ton J. Rabelink, Jan M. M. Van Lith, Marieke Sueters, Y K Onno Teng · 2021 · European Journal of Obstetrics & Gynecology and Reproductive Biology
  2. Acute pulmonary embolism. Part 1: epidemiology and diagnosis
    Renée A. Douma, Pieter Willem Kamphuisen, Harry Roger Buller · 2010 · Nature Reviews Cardiology
  3. Prevalence of thrombophilia according to age at the first manifestation of venous thromboembolism: results from the MAISTHRO registry
    Lea Weingarz, Jan Schwonberg, Marc Schindewolf, Carola Hecking, Zsuzsanna Wolf, Matthias Erbe, Adele Weber, Edelgard Lindhoff‐Last, Birgit Linnemann · 2013 · British Journal of Haematology
  4. Review: Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome
    Tadej Avčin, Earl D. Silverman · 2007 · Lupus
  5. Clinical utility of the global anti-phospholipid syndrome score for risk stratification: a pooled analysis
    Savino Sciascia, Massimo Radin, Giovanni Sanna, Irene Cecchi, Dario Roccatello, María Laura Bertolaccini · 2017 · Rheumatology
  6. Cellular and Molecular Mechanisms of Anti-Phospholipid Syndrome
    Marko Z. Radic, Debendra Pattanaik · 2018 · Frontiers in Immunology
  7. Stratifying management of rheumatic disease for pregnancy and breastfeeding
    Ian Giles, Chee‐Seng Yee, Caroline Gordon · 2019 · Nature Reviews Rheumatology
  8. Anti-Ku syndrome with elevated CK and anti-Ku syndrome with anti-dsDNA are two distinct entities with different outcomes
    Lionel Spielmann, Benoît Nespola, François Séverac, Emmanuel Andrès, Romain Kessler, Aurélien Guffroy, Vincent Poindron, Thierry Martin, Bernard Gény, Jean Sibilia et al. · 2019 · Annals of the Rheumatic Diseases
  9. Antiphospholipid Syndrome
    Diane George, Doruk Erkan · 2009 · Progress in Cardiovascular Diseases
  10. Paediatric systemic lupus erythematosus: prognostic impact of antiphospholipid antibodies
    Élodie Descloux, I. Durieu, Pierre Cochat, D. Vital Durand, J. Ninet, Nicole Fabien, Rolando Cimaz · 2007 · Rheumatology
  11. Primary thrombosis prophylaxis in antiphospholipid antibody-positive patients: where do we stand?
    Barbhaiya, Medha, Erkan, Doruk · 2011 · Current Rheumatology Reports
  12. B-cell directed therapies in antiphospholipid antibody syndrome — New directions based on murine and human data
    Saakshi Khattri, Gisele Zandman‐Goddard, Elena Peeva · 2012 · Autoimmunity Reviews
  13. Antiphospholipid syndrome: From pathogenesis to novel immunomodulatory therapies
    Cloé Comarmond, P. Cacoub · 2012 · Autoimmunity Reviews
  14. The role of immunity in the pathogenesis and development of pre‐eclampsia
    Huiqing Lu, Rong Hua Hu · 2019 · Scandinavian Journal of Immunology
  15. Antiphospholipid Syndrome in Pregnancy: New and Old Pathogenetic Mechanisms
    Silvia D’Ippolito, Greta Barbaro, Carmela Paciullo, Chiara Tersigni, Giovanni Scambia, Nicoletta Di Simone · 2023 · International Journal of Molecular Sciences
  16. Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management
    Jaume Alijotas‐Reig · 2012 · Lupus
  17. Catastrophic antiphospholipid syndrome and pregnancy: an experience of 13 cases
    Guillaume Hanouna, Nathalie Morel, D u Le Thi Huong, Laurence JOSSELIN-MAHR, D. Vauthier-Brouzes, David Saadoun, A. Kettaneh, Kateri Lévesque, Véronique Le Guern, François Goffinet et al. · 2013 · Rheumatology
  18. Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity
    Erin M. Scherer, Michael B. Zwick, Luc Teyton, Dennis R. Burton · 2007 · AIDS
  19. Pregnancy and renal outcomes in lupus nephritis: an update and guide to management
    Kate Bramham, May Ching Soh, Catherine Nelson‐Piercy · 2012 · Lupus
  20. Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up
    Y. Schoindre, Moez Jallouli, Marie‐Laure Tanguy, Pascale Ghillani‐Dalbin, Lionel Galicier, O. Aumaître, Camille Francès, Véronique Le Guern, Frédéric Lioté, Amar Smaïl et al. · 2014 · Lupus Science & Medicine
  21. Validity of the global anti-phospholipid syndrome score to predict thrombosis: a prospective multicentre cohort study
    Stéphane Zuily, Bas de Laat, S. Mohamed, Hilde Kelchtermans, Zakera Shums, Roger Albesa, Gary L. Norman, Claire Lamboux-Matthieu, Anne‐Christine Rat, J. Ninet et al. · 2015 · Rheumatology
  22. A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus
    Maria Grazia Lazzaroni, Francesca Dall’Ara, Micaela Fredi, Cecilia Nalli, Rossella Reggia, Andrea Lojacono, Francesca Ramazzotto, Sonia Zatti, Laura Andréoli, Anǵela Tincani · 2016 · Journal of Autoimmunity
  23. Antiphospholipid antibodies internalised by human syncytiotrophoblast cause aberrant cell death and the release of necrotic trophoblast debris
    Viall, Chez A., Chen, Qi, Liu, Bonnia, Hickey, Anthony, Snowise, Saul, Salmon, Jane E., Stone, Peter R., Chamley, Lawrence W. · 2013 · Journal of Autoimmunity
  24. Anti-Phosphatidylserine/Prothrombin Antibodies Are Associated with Adverse Pregnancy Outcomes
    Polona Žigon, Katja Perdan Pirkmajer, Matija Tomšič, Tanja Kveder, Borut Božič, Snežna Sodin Šemrl, Saša Čučnik, Aleš Ambrožič · 2015 · Journal of Immunology Research
  25. Impact of Persistent Antiphospholipid Antibodies on Risk of Incident Symptomatic Thromboembolism in Children: A Systematic Review and Meta-Analysis
    Gili Kenet, Sofia Aronis, Yackov Berkun, Mariana M. Bonduel, Anthony K.C. Chan, Neil A. Goldenberg, Susanne Holzhauer, Alfonso Iorio, Janna M. Journeycake, Ralf Junker et al. · 2011 · Seminars in Thrombosis and Hemostasis
  26. Use of direct oral anticoagulants in antiphospholipid syndrome
    Hannah Cohen, Maria Efthymiou, David Alan Isenberg · 2018 · Journal of Thrombosis and Haemostasis
  27. Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER)
    Anne Riveros-Frutos, Susana Holgado, Arantza Sanvisens, Irma Casas, Alejandro Olivé, Francisco Javier López-Longo, Jaime Calvo Alén, María Galindo-Izquierdo, Antonio Fernández‐Nebro, José María Pego‐Reigosa et al. · 2020 · Rheumatology
  28. The association between systemic autoimmune disorders and epilepsy and its clinical implications
    Claude Steriade, Maarten J. Titulaer, Annamaria Vezzani, Josemir W. A. S. Sander, Roland D. Thijs · 2020 · Brain
  29. Analytical and clinical performance of a new, automated assay panel for the diagnosis of antiphospholipid syndrome
    Philippe de Moerloose, Guido Reber, Jacek Musiał, Jef Arnout · 2010 · Journal of Thrombosis and Haemostasis
  30. Coagulation disorders in pregnancy: acquired and inherited thrombophilias
    Chiara Benedetto, Luca Marozio, Anna Maria Tavella, Loredana Salton, Sara Grivon, F. Di Giampaolo · 2010 · Annals of the New York Academy of Sciences
  31. Does seronegative antiphospholipid syndrome really exist?
    Ricard Cervera, Fabrizio Conti, Andrea Doria, Luca Iaccarino, Guido Valesini · 2011 · Autoimmunity Reviews
  32. Respiratory involvement in systemic lupus erythematosus
    D. Carmier, Sylvain Marchand-Adam, P. Diot, Élisabeth Diot · 2010 · Revue des Maladies Respiratoires
  33. Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS)
    Nancy Agmon‐Levin, Cristina Rosário, Bat-sheva Porat Katz, Gisele Zandman‐Goddard, Pier Luigi Meroni, Ricard Cervera, Ljudmila Stojanovich, Miri Blank, SS Pierangeli, Sonja Praprotnik et al. · 2013 · Lupus
  34. Comparison between three systems of classification criteria in juvenile systemic lupus erythematous
    Adriana Rodrigues Fonseca, MI Elsas, Marcelo Gerardin Poirot Land, Sheila Knupp Feitosa de Oliveira · 2014 · Rheumatology
  35. Prevalence and Thrombotic Risk Assessment of Anti-β2 Glycoprotein I Domain I Antibodies: A Systematic Review
    Massimo Radin, Irene Cecchi, Dario Roccatello, Pier Luigi Meroni, Savino Sciascia · 2017 · Seminars in Thrombosis and Hemostasis
  36. Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease
    Erkan, D, Unlu, O, Sciascia, S, Belmont, H M, Branch, D Ware, Cuadrado, M J, Gonzalez, E, Knight, J S, Uthman, I, Willis, R et al. · 2018 · Lupus
  37. Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives
    Favaloro, Emmanuel J., Mohammed, Soma, Curnow, Jennifer, Pasalic, Leonardo · 2019 · Pathology
  38. Prevalence of antibodies to prothrombin in solid phase (aPT) and to phosphatidylserine-prothrombin complex (aPS/PT) in patients with and without lupus anticoagulant
    Sciascia, Savino, Murru, Veronica, Garcia-Fernandez, Cesar, Sanna, Giovanni, Khamashta, Munther, Bertolaccini, Maria Laura · 2013 · Thrombosis and Haemostasis
  39. Thrombophilia and early pregnancy loss
    Kelly M. McNamee, Feroza Dawood, Roy G. Farquharson · 2011 · Best Practice & Research Clinical Obstetrics & Gynaecology
  40. Safety and efficacy of oral direct inhibitors of thrombin and factor Xa in antiphospholipid syndrome
    Nicolas Noël, Fabien Dutasta, Nathalie Costedoat-Chalumeau, Boris Bienvenu, Xavier Mariette A, Loïk Geffray, D. Sène, Rafik Belhadj Chaidi, Jean‐Marie Michot, O. Fain et al. · 2015 · Autoimmunity Reviews
  41. Increased chromosome 16 disomy rates in human spermatozoa and recurrent spontaneous abortions
    Michaela Neusser, Nina Rogenhofer, Stephanie Dürl, Robert Ochsenkühn, Matthias Trottmann, Vindi Jurinović, Ortrud K. Steinlein, Viktoria von Schönfeldt, Stefan Müller, Christian Thaler · 2015 · Fertility and Sterility
  42. Antibody binding to neuronal surface in movement disorders associated with lupus and antiphospholipid antibodies
    Russell Clive Dale, Katie Yin, ALICE DING, Vera Merheb, SOPHIE VARADKHAR, Damien McKay, Davinder Singh‐Grewal, Fabienne Brilot · 2011 · Developmental Medicine & Child Neurology
  43. Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management—An Insight into Future Approaches
    Cecilia Beatrice Chighizola, Tania Ubiali, Pier Luigi Meroni · 2015 · Journal of Immunology Research
  44. Anti-phospholipid induced murine fetal loss: Novel protective effect of a peptide targeting the β2 glycoprotein I phospholipid-binding site. Implications for human fetal loss
    Yeny Martinez de la Torre, Francesca Pregnolato, Fabio D’Amelio, Claudia Grossi, Nicoletta Di Simone, Fabio Pasqualini, Manuela Nebuloni, Pojen P. Chen, Silvia S. Pierangeli, Niccolò Bassani et al. · 2011 · Journal of Autoimmunity
  45. High levels of NK cells in the peripheral blood of patients affected with anti-phospholipid syndrome and recurrent spontaneous abortion: a potential new hypothesis
    Carlo Perricone, Caterina De Carolis, Roberto Giacomelli, Giuseppe Zaccari, Paola Cipriani, Emanuele Bizzi, Roberto Perricone · 2007 · Rheumatology
  46. Pathogenic role of anti-β2-glycoprotein I antibodies on human placenta: functional effects related to implantation and roles of heparin
    Nicoletta Di Simone, Pier Luigi Meroni, Marco D’Asta, Fiorella Di Nicuolo, M.C. D’Alessio, Alessandro Caruso · 2006 · Human Reproduction Update
  47. Hypercoagulability and Hypofibrinolysis and Risk of Deep Vein Thrombosis and Splanchnic Vein Thrombosis
    Jasper H. Smalberg, Marieke J.H.A. Kruip, Harry L.A. Janssen, Dingeman C. Rijken, Frank W.G. Leebeek, Moniek P.M. de Maat · 2011 · Arteriosclerosis Thrombosis and Vascular Biology
  48. Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome
    Cécile Yelnik, Elizabeth Kozora, Simone Appenzeller · 2016 · Current Rheumatology Reports
  49. Age of onset influences on clinical and laboratory profile of patients with systemic lupus erythematosus
    Rafael Hennemann Sassi, Jordana Vaz Hendler, Giovana Fagundes Piccoli, Andrese Aline Gasparin, Rafael Mendonça da Silva Chakr, João Carlos Tavares Brenol, Odirlei André Monticielo · 2016 · Clinical Rheumatology
  50. Subclinical Atherosclerosis in Systemic Lupus Erythematosus and Antiphospholipid Syndrome
    Fabrizio Conti, Francesca Romana Spinelli, Cristiano Alessandri, Massimo Pacelli, Fulvia Ceccarelli, Elisa Marocchi, Anna Montali, Antonella Capozzi, Brigitta Buttari, Elisabetta Profumo et al. · 2014 · Arteriosclerosis Thrombosis and Vascular Biology
  51. Delineating the deranged immune system in the antiphospholipid syndrome
    Lucas L. van den Hoogen, Joël A. G. van Roon, Timothy R. D. J. Radstake, Ruth D. E. Fritsch-Stork, Ronald H. W. M. Derksen · 2015 · Autoimmunity Reviews
  52. Semiquantitative interpretation of anticardiolipin and antiβ2glycoprotein I antibodies measured with various analytical platforms: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies
    Vandevelde, Arne, Chayoua, Walid, de Laat, Bas, Gris, Jean‐Christophe, Moore, Gary W., Musiał, Jacek, Zuily, Stéphane, Wahl, Denis, Devreese, Katrien M.J. · 2022 · Journal of Thrombosis and Haemostasis
  53. Lymphocytic Thrombophilic Arteritis
    Joyce Siong See Lee, Steven Kossard, Michael A. McGrath · 2008 · Archives of Dermatology
  54. Postthrombotic syndrome following upper extremity deep vein thrombosis in children
    Laura Avila, Lucy Duan, Amanda Cipolla, Ashley Kim, Walter H.A. Kahr, Suzan A. Williams, Leonardo Rodrigues Brandão · 2014 · Blood
  55. Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?
    Yehuda Shoenfeld, Pier Luigi Meroni, Elias Toubi · 2009 · Current Opinion in Rheumatology
  56. Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature
    Amelia Ruffatti, Piero Marson, Vittorio Pengo, Maria Favarò, Marta Tonello, Maria Bortolati, Daria Minucci, Giustina De Silvestro · 2006 · Autoimmunity Reviews
  57. A case-control study to assess the risk of immune thrombocytopenia associated with vaccines
    Lamiae Grimaldi‐Bensouda, Marc Michel, Elodie Aubrun, Pamela Leighton, Jean‐François Viallard, D. Adoué, Nadine Magy-Bertrand, G. Tisserand, Mehdi Khellaf, J.M. Durand et al. · 2012 · Blood
  58. Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women
    Nienke Folkeringa, Jan Leendert P. Brouwer, Fleurisca J. Korteweg, Nic J.G.M. Veeger, Jan Jaap Erwich, Jozien P. Holm, Jan van der Meer · 2007 · British Journal of Haematology
  59. Cofactor-independent antiphospholipid antibodies activate the NLRP3-inflammasome via endosomal NADPH-oxidase: implications for the antiphospholipid syndrome
    Nadine Müller‐Calleja, Antonia Köhler, Benjamin Siebald, Antje Canisius, Carolin Orning, Markus Philipp Radsak, Pamela Stein, René Mönnikes, Karl Johannes Lackner · 2015 · Thrombosis and Haemostasis
  60. Antiphosphatidylserine/Prothrombin Antibodies (aPS/PT) as Potential Markers of Antiphospholipid Syndrome
    Alexandru Daniel Vlagea, Antonio Gil, María Cuesta‐Corral, Florencia Arribas, Jesús Diez, Paz Lavilla, Dora Pascual‐Salcedo · 2012 · Clinical and Applied Thrombosis/Hemostasis
  61. Heavy menstrual bleeding in women treated with rivaroxaban and vitamin K antagonists and the risk of recurrent venous thromboembolism
    Agata Hanna Bryk, Magdalena Maria Piróg, Krzysztof Plens, Anetta Undas · 2016 · Vascular Pharmacology
  62. The treatment of anti-phospholipid syndrome: A comprehensive clinical approach
    Cecilia Beatrice Chighizola, Laura Andréoli, Maria Gerosa, Anǵela Tincani, Amelia Ruffatti, Pier Luigi Meroni · 2018 · Journal of Autoimmunity
  63. Femoral vein wall thickness measurement: A new diagnostic tool for Behçet’s disease
    Fatma Alıbaz-Öner, Rabia Ergelen, Yasin Yıldız, Mustafa Aldağ, Ayten Yazici, Ayşe Çefle, Ertan Koç, Bahar Artım-Esen, Gonca Mumcu, Tülin Ergun et al. · 2020 · Rheumatology
  64. Antiphospholipid syndrome management: a 2023 update and practical algorithm-based approach
    Amala Ambati, Jason S. Knight, Yu Zuo · 2023 · Current Opinion in Rheumatology
  65. HELLP Syndrome and Its Relationship with Antiphospholipid Syndrome and Antiphospholipid Antibodies
    Simone Appenzeller, Fernando Henrique Carlos de Souza, Alexandre Wagner Silva de Souza, Yehuda Shoenfeld, Jozélio Freire de Carvalho · 2011 · Seminars in Arthritis and Rheumatism
  66. Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies
    Ki‐Jo Kim, In‐Woon Baek, Chong‐Hyeon Yoon, Wan‐Uk Kim, Chul‐Soo Cho · 2013 · British Journal of Haematology
  67. Antiphospholipid syndrome: frequency, main causes and risk factors of mortality
    Gerard Espinosa, Ricard Cervera · 2010 · Nature Reviews Rheumatology
  68. Pregnancy and autoimmunity: A common problem
    Carlo Perricone, Caterina De Carolis, Roberto Perricone · 2012 · Best Practice & Research Clinical Rheumatology
  69. Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction
    Pál Soltész, Henrietta Dér, K. Veres, Renáta Laczik, Sándor Sipka, G. Szegedi, Péter Szodoray · 2008 · Rheumatology
  70. Recurrent thrombosis in patients with antiphospholipid antibodies and arterial thrombosis on antithrombotic therapy
    William G. Jackson, Clara Oromendia, Ozan Ünlü, Doruk Erkan, Maria Teresa DeSancho · 2017 · Blood Advances
  71. Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists
    Zelie Guitton, Louis Terriou, Jean‐Christophe Lega, Raphaële NOVE-JOSSERAND, Miguel Hie, Zahir Amoura, James Bruce Bussel, Mohamed Amine Hamidou, É. Rosenthal, Bertrand Lioger et al. · 2018 · Rheumatology
  72. Obstetric antiphospholipid syndrome
    Aleksandra Antovič, Maria Sennström, Katarina A Bremme, Elisabet Svenungsson · 2018 · Lupus Science & Medicine
  73. Pregnancies Complicated with Antiphospholipid Syndrome: The Pathogenic Mechanism of Antiphospholipid Antibodies
    Nicoletta Di Simone, Pier Luigi Meroni, Marco D’Asta, Fiorella Di Nicuolo, Silvia D’Ippolito, D'Alessio Maria Clara, Alessandro Caruso · 2007 · Annals of the New York Academy of Sciences
  74. NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus
    Petrus Linge, Sabine Arve-Butler, Lina M. Olsson, Dag Leonard, Christopher Sjöwall, Martina Frodlund, Iva Gunnarsson, Elisabet Svenungsson, Helena Tydén, Andreas Jönsen et al. · 2019 · Annals of the Rheumatic Diseases
  75. “Non-criteria” antiphospholipid syndrome: A nomenclature proposal
    Gilberto Pires da Rosa, Paulo Bettencourt, Ignasi Rodríguez‐Pintó, Ricard Cervera, Gerard Espinosa · 2020 · Autoimmunity Reviews
  76. Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case–control study over 10 years
    Sofia Ajeganova, Ingiäld Hafström, Johan Frostegård · 2021 · Lupus Science & Medicine
  77. Frequency of recurrent spontaneous abortion and its influence on further marital relationship and illness: The Okazaki Cohort Study in Japan
    Mayumi Sugiura‐Ogasawara, Sadao Suzuki, Yasuhiko Ozaki, Kinue Katano, Nobuhiro Suzumori, Tamao Kitaori · 2012 · Journal of obstetrics and gynaecology research
  78. Asymptomatic myocardial ischemic disease in antiphospholipid syndrome: A controlled cardiac magnetic resonance imaging study
    Karim Sacré, B. Brihaye, Fabien Hyafil, Jean‐Michel Serfaty, Brigitte Escoubet, Maria‐Christina Zennaro, Olivier Lidove, Jean‐Pierre Laissy, T. Papo · 2010 · Arthritis & Rheumatism
  79. Other Immune Thrombocytopenias
    Howard A. Liebman · 2007 · Seminars in Hematology
  80. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus
    Tünde Tarr, Gabriella Lakos, Harjit Pal Bhattoa, G. Szegedi, Yehuda Shoenfeld, E. Kiss · 2007 · Lupus
  81. New Tests to Detect Antiphospholipid Antibodies: Anti-Domain I Beta-2-Glycoprotein-I Antibodies
    Cecilia Beatrice Chighizola, Maria Gerosa, Pier Luigi Meroni · 2014 · Current Rheumatology Reports
  82. Obstetric antiphospholipid syndrome: A recent classification for an old defined disorder
    Silvia D’Ippolito, Pier Luigi Meroni, Takao Koike, Manuela Veglia, Giovanni Scambia, Nicoletta Di Simone · 2014 · Autoimmunity Reviews
  83. Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention
    Maria Wigren, J. Nilsson, Mariana J. Kaplan · 2015 · Journal of Internal Medicine
  84. Lower Extremity Ulcers in Systemic Sclerosis: Features and Response to Therapy
    Victoria K. Shanmugam, Patricia Price, Christopher E. Attinger, Virginia D. Steen · 2010 · International Journal of Rheumatology
  85. Recurrent pregnancy loss and obesity
    Mayumi Sugiura‐Ogasawara · 2014 · Best Practice & Research Clinical Obstetrics & Gynaecology
  86. Evaluation of Clinical Outcomes and Renal Vascular Pathology among Patients with Lupus
    Claire E.H. Barber, Andrew M. Herzenberg, Ellie Aghdassi, Jiandong Su, Wendy Y. W. Lou, Qian Gan, Jonathan Yip, Samih H. Nasr, David Brynmor Thomas, James William Scholey et al. · 2012 · Clinical Journal of the American Society of Nephrology
  87. HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus
    Emeli Lundström, Johanna T. Gustafsson, Andreas Jönsen, Dag Leonard, Agneta Zickert, Kerstin Elvin, Gunnar K. Sturfelt, Gunnel Nordmark, Anders A Bengtsson, Ulf Sundin et al. · 2012 · Annals of the Rheumatic Diseases
  88. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A preliminary first year report
    Jaume Alijotas‐Reig, Raquel Ferrer‐Oliveras · 2012 · Lupus
  89. Peripheral natural killer cell activity as a predictor of recurrent pregnancy loss: a large cohort study
    Katano, Kinue, Suzuki, Sadao, Ozaki, Yasuhiko, Suzumori, Nobuhiro, Kitaori, Tamao, Sugiura-Ogasawara, Mayumi · 2013 · Fertility and Sterility
  90. Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study
    Olga Amengual, Ricardo R Forastiero, Mayumi Sugiura‐Ogasawara, Kotaro Otomo, Kenji Oku, Catarina Favas, José Delgado Alves, Polona Žigon, Aleš Ambrožič, Matija Tomšič et al. · 2016 · Lupus
  91. Levamisole-induced vasculopathy: A systematic review
    Anaïs Dartevel, Benjamin Chaigne, Laurence Chauvelot‐Moachon, Florian Grenier, Nicolas Dupin, Loı̈c Guillevin, Laurence Bouillet, Luc Mouthon · 2018 · Seminars in Arthritis and Rheumatism
  92. Coagulopathy in COVID-19: Focus on vascular thrombotic events
    Wei Shi, Jiagao Lv, Li Lin · 2020 · Journal of Molecular and Cellular Cardiology
  93. Neurologic Manifestations of the Antiphospholipid Syndrome — an Update
    Miguel Leal Rato, Matilde Bandeira, Vasco C. Romão, Diana Aguiar de Sousa · 2021 · Current Neurology and Neuroscience Reports
  94. TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development
    Carlo Perricone, Cinzia Ciccacci, Fulvia Ceccarelli, Davide Di Fusco, Francesca Romana Spinelli, Enrica Cipriano, Giuseppe Novelli, Guido Valesini, Fabrizio Conti, Paola Borgiani · 2013 · Immunogenetics
  95. Standards and reference materials for the anticardiolipin and anti-β2glycoprotein I assays: A report of recommendations from the APL Task Force at the 13th International Congress on Antiphospholipid Antibodies
    Silvia S. Pierangeli, Emmanuel J. Favaloro, Gabriella Lakos, Pier Luigi Meroni, Anǵela Tincani, Richard C. W. Wong, Edward N. Harris · 2011 · Clinica Chimica Acta
  96. How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy
    Schulman, Sam · 2017 · Blood
  97. Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation
    Martirosyan, Anush, Aminov, Rustam, Manukyan, Gayane · 2019 · Frontiers in Immunology
  98. Correct laboratory approach to APS diagnosis and monitoring
    Pengo, V., Banzato, A., Denas, G., Jose, S. Padayattil, Bison, E., Hoxha, A., Ruffatti, A. · 2013 · Autoimmunity Reviews
  99. Enhanced type I interferon gene signature in primary antiphospholipid syndrome: Association with earlier disease onset and preeclampsia
    Michelle Remião Ugolini Lopes, Giovana Tardin Torrezan, Ana Paula Rossi Gândara, Eloísa Helena Ribeiro Olivieri, Iana Sousa Nascimento, Erica Okazaki, Eloísa Bonfá, Dirce Maria Carraro, DANIELI CASTRO OLIVEIRA DE ANDRADE · 2019 · Autoimmunity Reviews
  100. Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
    Emmanuel J. Favaloro, Leonardo Pasalic · 2022 · Research and Practice in Thrombosis and Haemostasis